KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 1,241,621 Value ($000) $51,217 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 1,134,186 Value ($000) $44,040 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 791,305 Value ($000) $21,895 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 397,745 Value ($000) $8,834 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 320,007 Value ($000) $6,330 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 320,997 Value ($000) $8,022 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 169,648 Value ($000) $3,167 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	1,241,621	$51,217	$40.11	$35.20 - $44.42
Q3 2025	1,134,186	$44,040	$32.49	$26.27 - $39.00
Q2 2025	791,305	$21,895	$25.46	$18.25 - $30.69
Q1 2025	397,745	$8,834	$20.58	$17.82 - $24.31
Q4 2024	320,007	$6,330	$22.82	$19.47 - $28.15
Q3 2024	320,997	$8,022	$24.36	$17.38 - $27.92
Q2 2024	169,648	$3,167	$18.73	$16.56 - $20.52